Tissue culture-based rabies vaccines: vaccine production technology transfer.
Overcoming stagnation in rabies prevention programs in the developing world requires national strategies that include plans to adopt existing facilities for production of low-cost efficacious tissue culture-based vaccine. Transfer of tissue culture technology for the production of rabies vaccine has been supported by the World Health Organization and The Rockefeller Foundation, and in the fall of 1986 the location of the optimal site for the initial technology transfer program was agreed upon. Funds were provided to assemble training staff and to purchase the supplies and equipment to furnish a production facility at the Veterinary Products Company of Colombia (VECOL) located in Bogota, Colombia.
Halstead
S B
SB
Health Services Division, Rockefeller Foundation, New York 10036.
D000818:Animals; D003105:Colombia; D003906:Developing Countries; D006801:Humans; D011818:Rabies / Q000517:prevention & control*; D011819:Rabies Vaccines; D013673:Technology Assessment, Biomedical / Q000191:economics*; D015164:Vaccines, Inactivated; D014709:Vero Cells; D014944:World Health Organization
D011819:Rabies Vaccines; D015164:Vaccines, Inactivated